KR
EN
About Us
Technology
IP/Paper
IR/PR
Notice
Contact
Mission & Vision
Leadership
Organization
History
Core Technologies
Tumoroid Biobank
Genomic Big Data of Tumoroid
Tumoroid-Based Drug Development
Pipeline
Drug Efficacy Assay
Precision Medicine
New Drug Development
IR
Public Disclosure
News
Awards and Recognitions
Partnerships
About Us
Mission & Vision
Leadership
Organization
History
Technology
Core Technologies
Pipeline
IP/Paper
IR/PR
IR
Public Disclosure
News
Awards and Recognitions
Partnerships
Notice
Contact
Technology
HOME
Technology
Pipeline
Technology
About Us
Technology
IP/Paper
IR/PR
Notice
Contact
Pipeline
Core Technologies
Pipeline
New Drug Development
Drug Efficacy Assay
Precision Medicine
New Drug Development
New Drug Development
New Drug Development
Drug Efficacy Assay
Precision Medicine
New Drug Development
TBDD (Tumoroid & big data based drug development)
Drug Development Pipeline
Pipeline
Big Data-Based
Target Identification
PoC &
Chemical Synthesis
Hit, lead Selection &
optimization
CMC &
Preclinical study
IND filling
Phase I
OC101
mCRC
OC102
Lung cancer
OC103
Drug-resistant lung cancers
Tumoroid-Based Drug Repositioning
Subject
Progress
Drug repositioning for mCRC
1st screening for 487 active molecules from chemical library (complete) => Selected 72 active molecules
2nd screening (Ongoing)